Catathrenia: Nighttime Groaning, Diagnosis, Treatment Limits and Safety

Catathrenia is a pattern of groaning or moaning during sleep, usually associated with a prolonged breath out. It differs from snoring and cannot be diagnosed reliably from the sound’s emotional meaning. Confidence is moderate in the clinical description; its mechanisms, population frequency and best treatment remain uncertain. Original corrected review.

Table of contents

• Evidence summary: a recognised pattern with thin treatment research
• What catathrenia is
• Mechanisms and the limits of classification
• Standard care and treatment context
• Supplements and breathing-exercise claims
• What a useful assessment and follow-up should measure
• Safety and symptoms that need assessment
• Medicines, sleep loss and overlapping symptoms
• Who should seek assessment
• Clinician-led testing and treatment decisions
• Animal and laboratory evidence
• Funding and source roles
• Frequently asked questions
• Sources and funding notes

Evidence summary: a recognised pattern with thin treatment research

The full corrected 2024 review was opened, including its methods and competing-interest statement. Its work funding remains unknown; the included literature is heterogeneous and does not clear an independent treatment verdict. An older original clinical series supplies additional context but is retrospective, referral-selected and financially unresolved. Corrected review; Original series.

This guide does not convert treatment correlations, selected case responses or clinic counts into a causal benefit or population prevalence. When a condition is unusual, precise descriptions are useful, but numerical precision can be misleading if the sample and methods cannot answer the question.

What catathrenia is

Catathrenia describes sleep-related expiratory groaning. The sound may occur in clusters and be noticed mainly by a bed partner. The differential includes snoring, apnea, other airway sounds, sleep talking and some neurological events. The exact pattern matters more than whether an observer calls the sound a moan, hum or groan. Clinical description.

An alarming sound does not reveal a person’s intentions, emotions or dream content. A household should describe what was heard without assigning embarrassment or blame. A useful account also records whether breathing looked difficult, awareness changed or sleep was repeatedly disrupted.

A one-off recording is not a complete medical assessment. If the concern is persistent, bring observations to a clinician rather than repeatedly waking the sleeper to demand an explanation they may not remember.

Mechanisms and the limits of classification

The older clinical series examined a characteristic airflow sequence and its relationship to sleep arousals. Its authors also highlighted uncertainty about pathogenesis and classification. It does not establish that every nocturnal groan has one airway mechanism or belongs exclusively to one sleep stage. Physiological context.

Snoring, in contrast, arises from vibration of relaxed upper-airway tissue during breathing. The distinction is useful, but an untrained recording alone cannot exclude coexisting obstruction. Snoring mechanism.

Mechanistic uncertainty is a reason to be explicit about what a test must capture. A commercial explanation that confidently names one muscle or recommends one exercise may exceed the clinical evidence. Plausibility is not proof of treatment benefit.

Standard care and treatment context

Clinical care first determines whether there is another breathing or sleep disorder and whether the sound creates meaningful impairment. A person with confirmed obstructive apnea needs an apnea treatment discussion even if groaning is the symptom that prompted the appointment. Assessment; Apnea care.

Positive-airway-pressure and medicine approaches appear in the catathrenia literature, but the selected reports reviewed here do not provide a financially cleared randomised comparison. There is no universal pressure setting, sedative choice or guaranteed resolution recommended in this article. Report limitations.

The person’s priorities matter. Some want to understand the sound, some struggle with sleep disruption and some have a separate clinical problem. A reasonable consultation clarifies which problem treatment is intended to solve and whether the burden or adverse effects would outweigh that target.

Supplements and breathing-exercise claims

No supplement receives a catathrenia treatment recommendation from this source set. Melatonin’s general safety limitations do not become evidence that it stops groaning. Product quality, interaction and long-term uncertainties remain relevant if it is considered for a separate sleep problem. Melatonin safety.

Breathing, singing, relaxation or tongue exercises may be promoted online. A personal account of less sound on a few nights is not a controlled trial or proof of the cause. The reviewed sources do not establish a routine that can be promised to correct catathrenia.

Do not turn an exercise into deliberate breath-holding, forced airway manipulation or equipment adjustment. If the symptom comes with actual breathing difficulty, assessment should address that concern directly.

What a useful assessment and follow-up should measure

Separate the outcomes: sound frequency, partner sleep disruption, the sleeper’s daytime functioning and any diagnosed breathing disorder. Less noise is not automatically evidence that sleep quality or oxygenation improved. More sound does not automatically mean more physiological harm.

An observation diary can describe which nights are affected, whether the person snores or gasps, and whether symptoms followed a change in medicine or routine. Keep the task manageable; repeated overnight surveillance can itself disrupt both people’s sleep.

If treatment is offered, ask how the target will be reassessed and what would justify continuing it. Comfort, tolerability and a clear review point are important when definitive efficacy evidence is limited. Do not treat failure of one trial as proof that the symptom is imagined.

Safety and symptoms that need assessment

Breathing pauses, gasping, choking and important daytime sleepiness raise a separate apnea question. They should not be dismissed as part of a benign sound pattern. Apnea signs.

If an episode includes a first suspected seizure, a prolonged seizure or repeated events without recovery, seek urgent medical care according to local guidance. A sound recorded during an event does not determine whether it is neurological. Seizure safety.

Do not drive or undertake hazardous tasks when alertness is inadequate. Arrange a safer alternative and seek assessment rather than relying on a sound diagnosis to certify daytime safety. Apnea and driving context.

Medicines, sleep loss and overlapping symptoms

Bring prescribed medicines, supplements, sleep aids, alcohol use and recent changes to the consultation. A time relationship may help the clinical investigation but does not prove causation. Avoid changing a long-term medicine solely to produce a quieter recording.

A person can have more than one sleep complaint. Insomnia, snoring, groaning and daytime sleepiness should be described separately rather than forced into one explanation. If a treatment improves only one target, the remaining symptom still needs its own review.

Combining sleep products can create adverse effects while making it difficult to identify which change mattered. A clinician or pharmacist should evaluate the actual combination, especially if neurological medicines or breathing problems are present. General supplement interaction context.

Who should seek assessment

Assessment is appropriate when the sound is persistent and disruptive, the pattern is unclear, or breathing or daytime symptoms accompany it. Seek help sooner for injury, altered awareness or new significant illness rather than waiting to find the right internet name.

A child’s or infant’s unusual breathing sound needs age-appropriate assessment, particularly with difficulty breathing or feeding. Adult reports should not be translated into child sedatives, airway devices or positioning instructions.

A partner’s observations can be useful, but the sleeper should remain involved in decisions about recordings and appointments. Share recordings for care with consent where possible, and keep them out of public entertainment or humiliation.

Clinician-led testing and treatment decisions

A specialist may consider attended sleep testing with audio/video and breathing signals to distinguish the pattern from other events. The original clinical series illustrates why synchronised information can be more informative than a sound alone. The test should answer the actual clinical question. Testing context.

Ask what was found, whether an additional disorder was identified and which uncertainty remains. If a medicine or airway treatment is discussed, clarify whether it targets catathrenia, confirmed apnea or a different coexisting complaint.

No home diagnostic threshold, device setting or personalised regimen is supplied. The plan should explain the rationale, possible harms, follow-up and what changes would require urgent care.

Animal and laboratory evidence

No animal or laboratory result is used to endorse a catathrenia treatment. A model of vocal-cord vibration or breathing transitions cannot establish a clinical cure. Human diagnostic and treatment uncertainty remains visible rather than being filled by an attractive mechanism.

Funding and source roles

The corrected 2024 original and the older original clinical manuscript were opened. A no-competing-interest statement in the review does not supply missing work funding. Neither source financially clears an independent comparative treatment effect; public education supplies separate apnea and safety context.

Tier describes financial proximity; A–D describes credibility for the stated source role. Neither is a clinical certainty grade. Unknown finances remain unknown. Manufacturer- and sponsor-funded efficacy is excluded from the independent verdict; attributed clinical guidance is identified as guidance.

Frequently asked questions

Is catathrenia the same as snoring?
No. It describes a different sound and breathing pattern, though symptoms can overlap.

Does groaning reveal a dream or hidden feeling?
A sound is not a reliable interpretation of emotion or intention.

Is CPAP a guaranteed cure?
No universal catathrenia result is established here. Confirmed apnea may still need its own treatment.

Can I diagnose it from audio?
Audio may illustrate the concern but cannot answer every breathing or neurological question.

Sources and funding notes

The 2024 review was corrected for author spelling and affiliation; those corrections are reflected in source provenance. The accessible 2016/17 manuscript supplies no study-work financial or personal-disclosure statement. A separate 2017 review and AASM Sleep Education page were access-blocked and were not treated as read.

• Blaszczyk and colleagues: corrected catathrenia review, 2024 — Nocturnal expiratory groaning and diagnostic uncertainty; no pooled treatment benefit adopted.
• Drakatos and colleagues: original catathrenia series, 2016/17 — Audio/video and breathing-pattern context; prevalence and treatment percentages not generalised.
• NHS: snoring, August 2023 — Upper-airway vibration differs from expiratory groaning.
• NHLBI: apnea diagnosis — Assessment of a competing breathing disorder.
• NHLBI: apnea symptoms — Pauses, gasping and sleepiness require a separate question.
• NHLBI: apnea treatment — Treatment of confirmed apnea, not a guaranteed groaning cure.
• NHLBI: living with apnea — Alertness safety and clinical follow-up.
• NHS: epilepsy — Seizure differential and urgent care.
• NCCIH: melatonin — General safety and evidence limitations; not proof of a cure.
• NHLBI: budget and gift authority — Funding trace, not outcome evidence.
• NHS website: content and funding policy — Website funding and editorial safeguards only.

Last reviewed: October 4, 2026. Educational information; no personal diagnosis, medication dose or supplement regimen is supplied. Local approval, product labels and clinical circumstances may differ.